✦ LIBER ✦

Economic analysis of high bolus dose tirofiban and sirolimus-eluting vs. abciximab and bare-metal stent in STRATEGY study

✍ Scribed by Paolo Squasi; Chiara Arcozzi; Francesca Basta; Gianfranco Percoco; Roberto Ferrari

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

IC4 ECONOMIC ANALYSIS OF THE STRATEGY ST

✍ N Mittmann; M Valgimigli; G Percoco; G Campo; P Squasi; C Arcozzi; P Malagutti; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

High-Dose BoluS TiRofibAn and Sirolimus

✍ Marco Valgimigli; Gianfranco Percoco; Giordano Cicchitelli; Fabrizio Ferrari; Da 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 92 KB

Two-by-two factorial comparison of high-

✍ Marco Valgimigli; Leonardo Bolognese; Maurizio Anselmi; Gianluca Campo; Alfredo 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Sex-specific benefits of sirolimus-eluti

✍ Giuseppe Ferrante; Patrizia Presbitero; Elena Corrada; Gianluca Campo; Leonardo 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 419 KB